The burgeoning popularity of semaglutide , initially for diabetes , is creating significant attention within the United Kingdom , prompting a notable shift in medication trends. Availability these compounds remains a complex challenge , with NHS approval currently limited and private clinics offering therapy at a premium . Concerns are being raised